Caricotamide

DB18950InvestigationalSmall molecule

Caricotamide is under investigation in clinical trial NCT00746590 (Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma).

Chemical structure of Caricotamide
Formula / weight
C8H11N3O2 · 181.195 g/mol (avg)
Also known as
1-(2-amino-2-oxoethyl)-1,4-dihydropyridine-3-carboxamide

Resolves to

Compound
UNIIMC09H30MFSCAS64881-21-6ChEMBLCHEMBL2000716
Structure
InChIKeyWEJRSYKFMCUCRQ-UHFFFAOYSA-NSMILESNC(=O)CN1C=CCC(=C1)C(N)=O
Targets
P16083NQO2

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Caricotamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In